These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8131802)

  • 21. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain MRI changes in phenylketonuria. Associations with dietary status.
    Thompson AJ; Tillotson S; Smith I; Kendall B; Moore SG; Brenton DP
    Brain; 1993 Aug; 116 ( Pt 4)():811-21. PubMed ID: 8353710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of migraine-related white matter hyperintensities after 3 years: a longitudinal MRI study.
    Erdélyi-Bótor S; Aradi M; Kamson DO; Kovács N; Perlaki G; Orsi G; Nagy SA; Schwarcz A; Dóczi T; Komoly S; Deli G; Trauninger A; Pfund Z
    Headache; 2015 Jan; 55(1):55-70. PubMed ID: 25319529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative prognostic utilities of early quantitative magnetic resonance imaging spin-spin relaxometry and proton magnetic resonance spectroscopy in neonatal encephalopathy.
    Shanmugalingam S; Thornton JS; Iwata O; Bainbridge A; O'Brien FE; Priest AN; Ordidge RJ; Cady EB; Wyatt JS; Robertson NJ
    Pediatrics; 2006 Oct; 118(4):1467-77. PubMed ID: 17015537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White matter pathology in phenylketonuria.
    Anderson PJ; Leuzzi V
    Mol Genet Metab; 2010; 99 Suppl 1():S3-9. PubMed ID: 20123467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Untreated non-phenylketonuric-hyperphenylalaninaemia: intellectual and neurological outcome.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Zass R; Koch HG
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S26-8. PubMed ID: 8828604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging.
    Vermathen P; Robert-Tissot L; Pietz J; Lutz T; Boesch C; Kreis R
    Magn Reson Med; 2007 Dec; 58(6):1145-56. PubMed ID: 18046700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A neurological evaluation of adult phenylketonuria in Northern Ireland.
    McDonnell GV; Esmonde TF; Hadden DR; Morrow JI
    Eur Neurol; 1998; 39(1):38-43. PubMed ID: 9476722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients.
    Ding XQ; Fiehler J; Kohlschütter B; Wittkugel O; Grzyska U; Zeumer H; Ullrich K
    J Magn Reson Imaging; 2008 May; 27(5):998-1004. PubMed ID: 18425822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR in phenylketonuria-related brain lesions.
    Dezortová M; Hájek M; Tintera J; Hejcmanová L; Syková E
    Acta Radiol; 2001 Sep; 42(5):459-66. PubMed ID: 11552882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spasticity and white matter abnormalities in adult phenylketonuria.
    McCombe PA; McLaughlin DB; Chalk JB; Brown NN; McGill JJ; Pender MP
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):359-61. PubMed ID: 1602307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White matter abnormalities in autism detected through transverse relaxation time imaging.
    Hendry J; DeVito T; Gelman N; Densmore M; Rajakumar N; Pavlosky W; Williamson PC; Thompson PM; Drost DJ; Nicolson R
    Neuroimage; 2006 Feb; 29(4):1049-57. PubMed ID: 16214373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Brain atrophy and disorders of the amino acid metabolism].
    Bickel H
    Monatsschr Kinderheilkd (1902); 1967 Apr; 115(4):254-8. PubMed ID: 5592531
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenylketonuria: MR imaging of the brain with clinical correlation.
    Pearsen KD; Gean-Marton AD; Levy HL; Davis KR
    Radiology; 1990 Nov; 177(2):437-40. PubMed ID: 2217781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurological deterioration in young adults with phenylketonuria.
    Thompson AJ; Smith I; Brenton D; Youl BD; Rylance G; Davidson DC; Kendall B; Lees AJ
    Lancet; 1990 Sep; 336(8715):602-5. PubMed ID: 1975386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cranial MRI in PKU: evaluation of a critical threshold for blood phenylalanine.
    Ullrich K; Weglage J; Schuierer G; Fünders B; Pietsch M; Koch HG; Hahn-Ullrich H
    Neuropediatrics; 1994 Oct; 25(5):278-9. PubMed ID: 7885543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR evidence of long T2 water in pathological white matter.
    Laule C; Vavasour IM; Mädler B; Kolind SH; Sirrs SM; Brief EE; Traboulsee AL; Moore GR; Li DK; MacKay AL
    J Magn Reson Imaging; 2007 Oct; 26(4):1117-21. PubMed ID: 17896375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical problems of the genetic heterogeneity in hyperphenylalaninemias].
    Grüttner R; Sternowsky HJ; Rybak C
    Monatsschr Kinderheilkd (1902); 1971 Nov; 119(11):600-4. PubMed ID: 5133646
    [No Abstract]   [Full Text] [Related]  

  • 39. An occipito-temporal syndrome in adolescents with optimally controlled hyperphenylalaninaemia.
    Lou HC; Toft PB; Andresen J; Mikkelsen I; Olsen B; Güttler F; Wieslander S; Henriksen O
    J Inherit Metab Dis; 1992; 15(5):687-95. PubMed ID: 1434507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.